Heron Therapeutics (HRTX) Work In Process (2016 - 2026)
Heron Therapeutics' (HRTX) quarterly Work In Process came in at $21.6 million in Q1 2026, down 25.32% YoY from $29.0 million in Q1 2025, and down 18.75% on a QoQ basis from $26.6 million in Q4 2025.
Heron Therapeutics (HRTX) Work In Process (2016 - 2026) Analysis & Trends
Heron Therapeutics (HRTX) has 11 years of Work In Process data on file, last reported at $21.6 million in Q1 2026.
- Quarterly Work In Process fell 25.32% year-over-year to $21.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $21.6 million (down 25.32% YoY) and the FY2025 annual result came in at $26.6 million, down 2.12% from the prior year.
- Work In Process declined to $21.6 million in Q1 2026, from $26.6 million in the prior quarter.
- In the past five years, Work In Process ranged from a high of $29.0 million in Q1 2025 to a low of $9.0 million in Q2 2023.
- A 5-year average of $19.5 million and a median of $18.4 million in 2024 frame the typical range for Work In Process.
- Annual changes were most pronounced in 2023 — Work In Process tumbled 55.18% — and 2024, when it soared 86.87%.
- Tracing HRTX's Work In Process over 5 years: stood at $20.7 million in 2022, then decreased by 29.79% to $14.6 million in 2023, then soared by 86.87% to $27.2 million in 2024, then slipped by 2.12% to $26.6 million in 2025, then decreased by 18.75% to $21.6 million in 2026.
- The last three Work In Process figures came in at $21.6 million (Q1 2026), $26.6 million (Q4 2025), and $26.3 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn |
| 10 | Heron Therapeutics | 58.32 Mn | 15.65 Mn | 26.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 24.28 Mn |
| Mar 31, 2026 | 21.62 Mn |
| Dec 31, 2025 | 26.61 Mn |
| Sep 30, 2025 | 26.34 Mn |
| Jun 30, 2025 | 26.15 Mn |
| Mar 31, 2025 | 28.95 Mn |
| Dec 31, 2024 | 27.19 Mn |
| Sep 30, 2024 | 18.35 Mn |
| Jun 30, 2024 | 16.05 Mn |
| Mar 31, 2024 | 16.29 Mn |
| Dec 31, 2023 | 14.55 Mn |
| Sep 30, 2023 | 16.42 Mn |
| Jun 30, 2023 | 9.02 Mn |
| Mar 31, 2023 | 17.91 Mn |
| Dec 31, 2022 | 20.72 Mn |
| Sep 30, 2022 | 11.63 Mn |
| Jun 30, 2022 | 20.12 Mn |
| Mar 31, 2022 | 13.30 Mn |
| Dec 31, 2021 | 20.94 Mn |
| Sep 30, 2021 | 11.55 Mn |